Filing Details
- Accession Number:
- 0001181431-12-059143
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-11-16 17:25:01
- Reporting Period:
- 2012-11-16
- Filing Date:
- 2012-11-16
- Accepted Time:
- 2012-11-16 17:25:01
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 893949 | Mednax Inc. | MD | Services-Hospitals (8060) | 650271219 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1093125 | Md Roger Medel | 1301 Concord Terrace Sunrise FL 33323 | Chief Executive Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2012-11-16 | 50,000 | $19.92 | 427,203 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-11-16 | 50,000 | $73.65 | 377,203 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options (Right to Buy) | Disposition | 2012-11-16 | 50,000 | $19.92 | 50,000 | $19.92 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2005-12-16 | 2012-12-16 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 480 | Indirect | By child |
Footnotes
- Stock Options granted pursuant to Issuer's Amended and Restated Stock Option Plan that were due to expire on December 16, 2012.
- Sales of shares were made pursuant to Reporting Person's 10b5-1 Trading Plan.
- Sales of shares were executed in eighty-eight (88) separate transactions with prices ranging from $73.06 to $74.58 for a weighted average sales price of $ 73.6511.
Billionaire Hedge Funds
